Sonali Quantius

Sonali Quantius is a highly experienced professional in the field of computational biology, currently serving as the Senior Director at Inari since October 2023. Prior to this role, Quantius founded Haplocare, functioning as the founder from September 2020 to October 2023, and led projects at ETH Zürich from March 2020 to September 2021. Quantius has held prominent positions, including Director of Computational Biology & Genetics at GlaxoSmithKline from July 2015 to July 2020, and Principal Research Scientist in Translational Bioinformatics at AstraZeneca R&D in 2014-2015. Earlier career experiences include roles at Eli Lilly & Company as a Senior Research Scientist and a Research Scientist in Computational Systems Biology, as well as a Postdoctoral Fellow at ETH Zürich, specializing in mass spectrometry-based proteomics. Quantius began an academic career at the Indian Institute of Technology, Bombay, as an Associate focused on Molecular Biophysics and earned a Ph.D. in Biochemistry from the University of Zurich, complemented by coursework at the London School of Economics and Political Science.